Patent: 10,172,817
✉ Email this page to a colleague
Summary for Patent: 10,172,817
| Title: | Treatment and diagnosis of colon cancer |
| Abstract: | The present invention discloses novel agents and methods for diagnosis and treatment of colon cancer. Also disclosed are related arrays, kits, and screening methods. |
| Inventor(s): | Tavazoie; Sohail (New York, NY), Loo; Jia M. (New York, NY) |
| Assignee: | The Rockefeller University (New York, NY) |
| Application Number: | 15/630,024 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,172,817
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Imclone Llc A Wholly-owned Subsidiary Of Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 12-Feb-04 | ⤷ Start Trial | 2037-06-22 |
| Imclone Llc A Wholly-owned Subsidiary Of Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 28-Mar-07 | ⤷ Start Trial | 2037-06-22 |
| Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 26-Feb-04 | ⤷ Start Trial | 2037-06-22 |
| Sanofi-aventis U.s. Llc | ZALTRAP | ziv-aflibercept | Injection | 125418 | 3-Aug-12 | ⤷ Start Trial | 2037-06-22 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
